Restoration Of Visually Evoked Center-surround Antagonism Using Photosensitive Opsins
University of California System: University of California, Berkeley
posted on 07/12/2010
Retinal degeneration culminates in mild to severe vision loss resulting from mutations in 196 different genes that cause the death of light sensitive photoreceptor cells, but leave the non-photosensitive inner retinal n eurons intact. Center-Surround Antagonism is a functional property of normal vision that allows for high acuity, contrast sensitivity and useful spatial vision. Restoring this property to a blind retina is crucial for re-establishing functional vision following rod and cone loss due to injury or retinal degeneration. Scientists at UC Berkeley have developed a method to directly insert light sensitive proteins (Photosensitive Opsins) into non-photosensitive retinal neurons, allowing those neurons to act as photoreceptors and restore center-surround antagonism.
Suggested Uses
- This method is a potential future therapy for restoring sight to the blind.
Advantages
- Gene therapy targeting non-photosensitive retinal neurons
- Gene therapy in the eye has been successful in animal trials
- Restores enhanced contrast and edge sensitivity
- Decreases “blur”
- Possible therapy for those that have suffered substantial photoreceptor loss
File Number: 18090
Disease: Ophthalmology and Optometry
| Patent Number(s): | 2011/0224145 |
|---|---|
| Copyright: | ©2010-2011, The Regents of the University of California |
This innovation currently is not available for online licensing. Please contact Javed Afzal at University of California System: University of California, Berkeley for more information.
Find more innovations
